Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 440 (LINC00440) is a human gene that encodes a **long non-coding RNA (lncRNA)**[3][1][11]. Located on chromosome 13, this RNA does not produce a protein product[13]. LINC00440 belongs to the lncRNA class, a family of RNA molecules known to play regulatory roles in gene expression and chromatin architecture, typically through epigenetic or transcriptional mechanisms[3][11]. There is no evidence to indicate that LINC00440 is a conventional therapeutic target such as a receptor, enzyme, transporter, or direct disease driver. Its molecular function remains largely uncharacterized in the publicly available literature, and there are no known drugs or biomarkers associated with this RNA. It is primarily catalogued and referenced in gene annotation resources, and is not currently known to present notable safety or therapeutic challenges[3][1][5][9][11][13][14].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 440 (LINC00440).